263 related articles for article (PubMed ID: 36291127)
21. Geniposide improves insulin resistance through AMPK-mediated Txnip protein degradation in 3T3-L1 adipocytes.
Zhao W; Pu M; Shen S; Yin F
Acta Biochim Biophys Sin (Shanghai); 2021 Feb; 53(2):160-169. PubMed ID: 33349852
[TBL] [Abstract][Full Text] [Related]
22. Txnip balances metabolic and growth signaling via PTEN disulfide reduction.
Hui ST; Andres AM; Miller AK; Spann NJ; Potter DW; Post NM; Chen AZ; Sachithanantham S; Jung DY; Kim JK; Davis RA
Proc Natl Acad Sci U S A; 2008 Mar; 105(10):3921-6. PubMed ID: 18322014
[TBL] [Abstract][Full Text] [Related]
23. Atypical defects resulting in growth hormone insensitivity.
Wit JM; de Luca F
Growth Horm IGF Res; 2016 Jun; 28():57-61. PubMed ID: 26670721
[TBL] [Abstract][Full Text] [Related]
24. Redox-dependent and independent effects of thioredoxin interacting protein.
Cao X; He W; Pang Y; Cao Y; Qin A
Biol Chem; 2020 Oct; 401(11):1215-1231. PubMed ID: 32845855
[TBL] [Abstract][Full Text] [Related]
25. High beta-cell mass prevents streptozotocin-induced diabetes in thioredoxin-interacting protein-deficient mice.
Masson E; Koren S; Razik F; Goldberg H; Kwan EP; Sheu L; Gaisano HY; Fantus IG
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1251-61. PubMed ID: 19223654
[TBL] [Abstract][Full Text] [Related]
26. Thioredoxin regulates adipogenesis through thioredoxin-interacting protein (Txnip) protein stability.
Chutkow WA; Lee RT
J Biol Chem; 2011 Aug; 286(33):29139-29145. PubMed ID: 21705327
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of IGFBPs in Laron syndrome-derived lymphoblastoid cell lines: Potential correlation with reduced cancer incidence.
Somri L; Sarfstein R; Lapkina-Gendler L; Nagaraj K; Laron Z; Bach LA; Werner H
Growth Horm IGF Res; 2018 Apr; 39():6-12. PubMed ID: 29208357
[TBL] [Abstract][Full Text] [Related]
28. W2476 ameliorates β-cell dysfunction and exerts therapeutic effects in mouse models of diabetes via modulation of the thioredoxin-interacting protein signaling pathway.
Li T; Lin GY; Zhong L; Zhou Y; Wang J; Zhu Y; Feng Y; Cai XQ; Liu Q; Nosjean O; Boutin JA; Renard P; Yang DH; Wang MW
Acta Pharmacol Sin; 2017 Jul; 38(7):1024-1037. PubMed ID: 28502980
[TBL] [Abstract][Full Text] [Related]
29. Thioredoxin-interacting protein: A new therapeutic target in bone metabolism disorders?
Jiang N; Liu J; Guan C; Ma C; An J; Tang X
Front Immunol; 2022; 13():955128. PubMed ID: 36059548
[TBL] [Abstract][Full Text] [Related]
30. Deletion of thioredoxin-interacting protein improves cardiac inotropic reserve in the streptozotocin-induced diabetic heart.
Myers RB; Fomovsky GM; Lee S; Tan M; Wang BF; Patwari P; Yoshioka J
Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1748-59. PubMed ID: 27037370
[TBL] [Abstract][Full Text] [Related]
31. Thioredoxin-interacting protein (Txnip) is a critical regulator of hepatic glucose production.
Chutkow WA; Patwari P; Yoshioka J; Lee RT
J Biol Chem; 2008 Jan; 283(4):2397-406. PubMed ID: 17998203
[TBL] [Abstract][Full Text] [Related]
32. Phosphorylation of TXNIP by AKT Mediates Acute Influx of Glucose in Response to Insulin.
Waldhart AN; Dykstra H; Peck AS; Boguslawski EA; Madaj ZB; Wen J; Veldkamp K; Hollowell M; Zheng B; Cantley LC; McGraw TE; Wu N
Cell Rep; 2017 Jun; 19(10):2005-2013. PubMed ID: 28591573
[TBL] [Abstract][Full Text] [Related]
33. Redox regulation by nuclear factor erythroid 2-related factor 2: gatekeeping for the basal and diabetes-induced expression of thioredoxin-interacting protein.
He X; Ma Q
Mol Pharmacol; 2012 Nov; 82(5):887-97. PubMed ID: 22869588
[TBL] [Abstract][Full Text] [Related]
34. Thioredoxin-interacting protein expression is required for VEGF-mediated angiogenic signal in endothelial cells.
Abdelsaid MA; Matragoon S; El-Remessy AB
Antioxid Redox Signal; 2013 Dec; 19(18):2199-212. PubMed ID: 23718729
[TBL] [Abstract][Full Text] [Related]
35. Effects of GHR Deficiency and Juvenile Hypoglycemia on Immune Cells of a Porcine Model for Laron Syndrome.
Schilloks MC; Giese IM; Hinrichs A; Korbonits L; Hauck SM; Wolf E; Deeg CA
Biomolecules; 2023 Mar; 13(4):. PubMed ID: 37189345
[TBL] [Abstract][Full Text] [Related]
36. Dl-3-n-Butylphthalide Inhibits NLRP3 Inflammasome and Mitigates Alzheimer's-Like Pathology via Nrf2-TXNIP-TrX Axis.
Wang CY; Xu Y; Wang X; Guo C; Wang T; Wang ZY
Antioxid Redox Signal; 2019 Apr; 30(11):1411-1431. PubMed ID: 29634349
[TBL] [Abstract][Full Text] [Related]
37. Intracellular shuttling and mitochondrial function of thioredoxin-interacting protein.
Saxena G; Chen J; Shalev A
J Biol Chem; 2010 Feb; 285(6):3997-4005. PubMed ID: 19959470
[TBL] [Abstract][Full Text] [Related]
38. Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein.
Schulze PC; Yoshioka J; Takahashi T; He Z; King GL; Lee RT
J Biol Chem; 2004 Jul; 279(29):30369-74. PubMed ID: 15128745
[TBL] [Abstract][Full Text] [Related]
39. The GH-IGF1 axis and longevity. The paradigm of IGF1 deficiency.
Laron Z
Hormones (Athens); 2008; 7(1):24-7. PubMed ID: 18359741
[TBL] [Abstract][Full Text] [Related]
40. Nitrosative/oxidative stress conditions regulate thioredoxin-interacting protein (TXNIP) expression and thioredoxin-1 (TRX-1) nuclear localization.
Ogata FT; Batista WL; Sartori A; Gesteira TF; Masutani H; Arai RJ; Yodoi J; Stern A; Monteiro HP
PLoS One; 2013; 8(12):e84588. PubMed ID: 24376827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
